Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 633-636

  King, S M ^a   Saunders, E F ^a   Petric, M ^a   Gold, R ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Marrow transplantation; Measles vaccine; Mumps vaccine; Paediatric; Rubella vaccine

Indexed keywords

MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; RUBELLA ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FANCONI ANEMIA; HUMAN; IMMUNOFLUORESCENCE TEST; LEUKEMIA; MEASLES; MEASLES VACCINATION; METABOLIC DISORDER; MUMPS; PEDIATRICS; PRIORITY JOURNAL; RUBELLA; SEROCONVERSION; THALASSEMIA; VACCINATION;

ANEMIA, APLASTIC; ANTIBODIES, VIRAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; GENETIC DISEASES, INBORN; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; MEASLES VACCINE; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS VACCINE; MUMPS VIRUS; PROSPECTIVE STUDIES; RUBELLA VACCINE; RUBELLA VIRUS; SAFETY; TIME FACTORS; VACCINATION; VACCINES, COMBINED;

EID: 0029919559     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Atkinson WL, Orenstein WA, Krugman S. The resurgence of measles in the United States, 1989-1990. Ann Rev Med 1992; 43: 451-463.
2. Varughese P. Measles in Canada, 1994-1995. Measles Update 1995, LCDC, Health Canada, 3: 1-2.
3. Varughese P. Measles in Canada, 1994. Measles Update 1994, LCDC, Health Canada, 2: 3-5.
4. Monafo WJ, Haslam DB, Roberts RL et al. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J Pediatr 1994; 124: 273-276.
5. Valamari P, Lanning M, Tuokko H, Kouvalainen K. Measles virus in the cerebrospinal fluid in postvaccination immunosuppressive measles encephalopathy. Pediatr Infect Dis 1987; 6: 59-63.
6. Mitus A, Holloway A, Evans AE, Enders JF. Attenuated measles vaccine in children with acute leukemia. Am J Dis Child 1962; 103: 413-418.
7. Committee on Infectious Diseases, 1994 Red Book, 23rd edn. American Academy of Pediatrics, IL. USA, pp 53-57.
8. Aicardi J, Goutieres F, Arsenio-Nunes ML, Lebon P. Acute measles encephalitis in children with immunosuppression. Pediatrics 1977; 59: 232-239.
9. Breitfeld V, Hashida Y, Sherman FE et al. Fatal measles infection in children with leukemia. Lab Invest 1973; 28: 279-291.
10. National Advisory Committee on Immunizations (NACI). Canadian Immunization Guide, 4th edn, 1993, Health Canada, pp 70-76.
11. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657-663.
12. Witherspoon RP, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 1984; 21: 2-10.
13. Paulin T, Ringden O, Nilsson B. Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections. Bone Marrow Transplant 1987; 1: 317-328.
14. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
15. Giebink GS, Warkentin PI, Ramsay NKC, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986; 154: 590-596.
16. Engelhard D, Nagler A, Hardan I et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1-5.
17. Engelhard D, Handsher R, Naparstek E et al. The immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295-300.
18. Ljungman P, Wiklund-Hammarsten M, Duraj V et al. Response to tetanus immunization after bone marrow transplantation. J Infect Dis 1990; 162: 496-500.
19. Pauksen K, Hammarstrom V, Ljungman P et al Immunity of poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994; 8: 547-552.
20. Ljungman P, Fridell E, Lonnqvist B et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610-615.
21. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993; 123: 87-89.
22. Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. J Pediatr 1994; 125: 72-74.
23. McLaughlin M, Thomas P, Onorato I et al. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. Pediatrics 1988; 82: 229-233.
24. Palumbo P, Hoyt L, DeMasio K et al. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1992; 11: 1008-1114.